Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment

Andrews, Gavin; Sanderson, Kristy; Slade, Tim; Issakidis, Cathy

doi:10.1080/000486700536

Cited by 125 publications

(152 citation statements)

References 26 publications

Supporting

Mentioning

143

Contrasting

Unclassified

Order By: Relevance

“…Our results highlight the extensive clinical need in a context where the majority of affected individuals has no medical diagnosis nor seeks treatment (Andrews et al, 2000). In addition, the majority (85-95%) of individuals with mental health problems in Colombia does not access or cannot access the services they require Downloaded by [Derek Richards] at 01:24 10 January 2014…”

Section: Resultsmentioning

confidence: 82%

Point-Prevalence of Depression and Associated Risk Factors

Richards

Salamanca-Sanabria

2014

The Journal of Psychology

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 82%

Point-Prevalence of Depression and Associated Risk Factors

Richards

Salamanca-Sanabria

2014

The Journal of Psychology

View full text Add to dashboard Cite

“…The high burden of psychiatric disorders, especially depression and alcohol dependence, poses a major challenge for health services, since only a small proportion of individuals with these disorders seek care, and these diseases are frequently diagnosed when a patient seeks treatment for another comorbidity 42,43 . Primary health care services could thus play an important role in the identification and treatment of these disorders 44 .…”

Section: Discussionmentioning

confidence: 99%

“…Primary health care services could thus play an important role in the identification and treatment of these disorders 44 . However, such a strategy requires the development of treatment protocols as well as training and follow-up of the services provided by general practitioners, since evidence shows that such professionals lack the necessary knowledge to determine the most adequate treatment for these patients 43,45 .…”

Section: Discussionmentioning

confidence: 99%

Carga de doença no Brasil e suas regiões, 2008

et al. 2015

View full text Add to dashboard Cite

No presente estudo, o DALY (anos de vida perdidos ajustados por incapacidade), indicador de estudos de carga de doença, foi estimado para o Brasil em 2008. Entre os principais resultados, observam-se maior carga de doença no Norte e Nordeste e preponderância das doenças crônicas não transmissíveis em todas as regiões do país, em particular as doenças cardiovasculares, os transtornos mentais, com destaque para a depressão, o diabetes e a doença pulmonar obstrutiva crônica. Também chama a atenção a elevada carga dos homicídios e dos acidentes de trânsito. O perfil epidemiológico apresenta-se ainda mais complexo quando se considera a carga não desprezível das doenças transmissíveis, das condições maternas, das condições perinatais e das deficiências nutricionais. As análises empreendidas ao longo do estudo possibilitaram conhecer de forma mais detalhada o status de saúde da população, evidenciando a demanda por ações transversais, que vão além de políticas específicas circunscritas à área de saúde, bem como a necessidade de ampliar o escopo de preocupação com a qualidade das informações sobre morbimortalidade no Brasil.

show abstract

“…Only a minority of people with mental disorders worldwide consult a physician (Andrews et al, 2000;Kapczinski et al, 2001). Although there is evidence from industrialized countries that not all people with mental disorders receive adequate treatment, health systems in developing countries are often not able to provide even the most essential mental health care (Andrews et al, 2000).…”

Section: Difficulty In Taking Medicationmentioning

confidence: 99%

Evaluation of adherence to treatment by patients seen in a psychosocial care center in northeastern Brazil

Souza

Silva

Onofre

et al. 2011

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

In the treatment of mental disorders, nonadherence to medication, the main cause of psychiatric morbidity, is observed in about 50% of the cases and is responsible for numerous losses. This study evaluated adherence to drug treatment by patients seen in a Psychosocial Care Center (CAPS) in northeastern Brazil. Adherence to treatment was evaluated using the Haynes-Sackett and Morisky-Green-Levine tests. All patients registered in the CAPS were included in the study (n= 101). Only 11.88% of the patients adhered to drug treatment. The main reasons not to use medication were: oblivion (68.83%), feeling unwell after taking the medication (54.22%), not having money to buy the medication (43.83%), not finding the medication in the public health service (39.94%) and fear of harm that might be caused by the drug (28.90%). Furthermore, 85.1% of the patients did not know their diseases, 88.1% did not know their treatment, 86.4% did not feel good when they took their medication, and 88.1% took their medication incorrectly. The results revealed that the lack of information about diseases and drugs used, the nuisance posed by drug therapy and the low access to medications reduce adherence to treatment and, consequently, treatment effectiveness.Uniterms: Treatment adherence. Drug therapy/adherence to treatment. Mental health. Psychosocial Care Center.No tratamento de desordens mentais, a não-adesão ao tratamento ocorre em cerca de 50% dos casos e é responsável por inúmeros prejuízos, além de ser a principal causa de morbidade psiquiátrica. O presente estudo objetivou avaliar a adesão ao tratamento medicamentoso de pacientes atendidos em um Centro de Atenção Psicossocial (CAPS) no Nordeste do Brasil. A avaliação da adesão ao tratamento foi feita através dos testes de Haynes-Sackett e Morisky-Green-Levine. Todos os pacientes cadastrados no CAPS foram incluídos no estudo (n = 101). Observou-se que apenas 11,88% dos pacientes aderiram ao tratamento medicamentoso. As principais razões para o não uso dos medicamentos foram: esquecimento (68,83%), sentir-se mal após a ingestão de medicamentos (54,22%), não ter dinheiro para comprar medicamentos (43,83%), não encontrar os medicamentos no serviço público de saúde (39,94%) e medo dos danos causados pelos medicamentos (28,90%). Além disso, observou-se que 85,1% dos pacientes não conheciam suas doenças, 88,1% não conheciam seus tratamentos, 86,4% não se sentiam bem quando usavam medicamentos e 88,1% usavam os medicamentos incorretamente. Os resultados demonstram que a falta de informação sobre doenças e medicamentos, os danos decorrentes da terapia medicamentosa e o baixo acesso aos medicamentos comprometem a adesão ao tratamento e, consequentemente, a eficácia do tratamento. INTRODUCTIONPoor adherence to medications prescribed for chronic conditions has been cited as a global problem that may lead to increased morbidity and mortality (WHO, 2003; NEHI, 2009). It increases the costs within healthcare systems and contributes to substantial worsening of disease control and quality of life ...

show abstract

Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment

Cited by 125 publications

References 26 publications

Point-Prevalence of Depression and Associated Risk Factors

Point-Prevalence of Depression and Associated Risk Factors

Carga de doença no Brasil e suas regiões, 2008

Evaluation of adherence to treatment by patients seen in a psychosocial care center in northeastern Brazil

Contact Info

Product

Resources

About